MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Journal of Medicinal Chemistry
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

762 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
762 works in the cohort · of 4,299,418page 15 of 16

Labels cover 4 of 762 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 762 of 762 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affunlabeled
The Chimera That Curbs Appetite
Leonard G. Luyt
2018· letter· en· Journal of Medicinal Chemistry· Neuroscience
machine prediction:candidate · noneconsensus · none
4
citations
fundno affunlabeled
Development of a Potent and Selective G2A (GPR132) Agonist
Víctor Hernández‐Olmos, Jan Heering, Beatrice Marinescu, Tina Schermeng, Vladimir V. Ivanov, Yurii S. Moroz +19 more
2024· article· en· Journal of Medicinal Chemistry· Medicine
machine prediction:candidate · noneconsensus · none
3
citations
affunlabeled
Discovery of a Potent, Selective, and Cell-Active SPIN1 Inhibitor
Yan Xiong, Holger Greschik, C. Johansson, Ludwig Seifert, Vicki Gamble, Kwang‐Su Park +13 more
2024· article· en· Journal of Medicinal Chemistry· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
3
citations
affunlabeled
Use of P450 Enzymes for Late-Stage Functionalization in Drug Discovery
Vincent Kwok‐Man Poon, Christopher Bailey, Sandra Carvalho, Stephen Patterson, James W. B. Fyfe, Olga Semenova +12 more
2025· article· en· Journal of Medicinal Chemistry· Pharmacology, Toxicology and Pharmaceutics
machine prediction:candidate · noneconsensus · none
3
citations
afffundunlabeled
From a Cone Snail Toxin to a Competitive MC4R Antagonist
Steve Reynaud, Suli‐Anne Laurin, Justyna Ciolek, Peggy Barbe, Anne-Cécile van Baelen, Michaël Susset +13 more
2022· article· en· Journal of Medicinal Chemistry· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
2
citations

How this was built: Screen · Findings · About